Crossref
Sentinel lymph node biopsy in breast cancer: A comparative trial of indocyanine green fluorescent imaging versus technetium-99m
European Journal of Cancer · 2026-03 · 237 · 116562
DOI: 10.1016/j.ejca.2026.116562 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von D. Zahoor und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zahoor, D., & Qudoos, A. (2026). Sentinel lymph node biopsy in breast cancer: A comparative trial of indocyanine green fluorescent imaging versus technetium-99m. European Journal of Cancer, 237, 116562. https://doi.org/10.1016/j.ejca.2026.116562
Vancouver
Zahoor D, Qudoos A. Sentinel lymph node biopsy in breast cancer: A comparative trial of indocyanine green fluorescent imaging versus technetium-99m. European Journal of Cancer. 2026;237:116562. doi:10.1016/j.ejca.2026.116562
BibTeX
@article{Zahoor2026,
author = {Zahoor, D. and Qudoos, A.},
title = {Sentinel lymph node biopsy in breast cancer: A comparative trial of indocyanine green fluorescent imaging versus technetium-99m},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116562},
doi = {10.1016/j.ejca.2026.116562}
}
EUVIMED